Trevena Inc (TRVN)
0.4157
0.00 (0.00%)
USD |
NASDAQ |
May 10, 16:00
0.4157
0.00 (0.00%)
After-Hours: 20:00
Trevena Cash from Operations (TTM): -33.04M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -33.04M |
September 30, 2023 | -37.71M |
June 30, 2023 | -39.39M |
March 31, 2023 | -44.09M |
December 31, 2022 | -51.48M |
September 30, 2022 | -53.43M |
June 30, 2022 | -53.95M |
March 31, 2022 | -54.04M |
December 31, 2021 | -50.20M |
September 30, 2021 | -44.71M |
June 30, 2021 | -36.31M |
March 31, 2021 | -29.59M |
December 31, 2020 | -21.39M |
September 30, 2020 | -21.07M |
June 30, 2020 | -24.50M |
March 31, 2020 | -22.20M |
December 31, 2019 | -23.67M |
September 30, 2019 | -22.56M |
June 30, 2019 | -20.33M |
March 31, 2019 | -22.65M |
December 31, 2018 | -25.38M |
Date | Value |
---|---|
September 30, 2018 | -31.48M |
June 30, 2018 | -39.25M |
March 31, 2018 | -52.21M |
December 31, 2017 | -71.26M |
September 30, 2017 | -87.14M |
June 30, 2017 | -100.07M |
March 31, 2017 | -100.36M |
December 31, 2016 | -91.55M |
September 30, 2016 | -75.72M |
June 30, 2016 | -63.03M |
March 31, 2016 | -54.69M |
December 31, 2015 | -40.08M |
September 30, 2015 | -41.27M |
June 30, 2015 | -40.28M |
March 31, 2015 | -39.66M |
December 31, 2014 | -39.78M |
September 30, 2014 | -37.28M |
June 30, 2014 | -33.10M |
March 31, 2014 | -27.76M |
December 31, 2013 | -24.24M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-54.04M
Minimum
Mar 2022
-20.33M
Maximum
Jun 2019
-35.98M
Average
-36.31M
Median
Jun 2021
Cash from Operations (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |
Theriva Biologics Inc | -19.00M |
Oragenics Inc | -7.291M |